Depot Extracts for Venom Immunotherapy: A Delphi Consensus on Safety and Efficacy

20260 citationsJournal Article

Authors

Valerio Pravettoni · Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Matteo Martini · Marche Polytechnic University

Donatella Bignardi · Azienda Ospedaliera S.Maria

Alessandro Buonomo · Agostino Gemelli University Polyclinic

M. Cilia · Experimental Station for the Industry of the Essential Oils and Citrus Products

Domenico Gargano · Azienda Ospedaliera S.Giuseppe Moscati

Abstract

Summary A Delphi consensus, funded by an immunotherapy manufacturer, was reached on Depot Venom Immunotherapy (dVIT). dVIT safety is similar to aqueous VIT (rush and ultra‐rush protocols), with immunological specific enhancements.

Topics & Keywords

Food Allergy and Anaphylaxis Research Allergic Rhinitis and Sensitization Healthcare and Venom Research

Publication Details

Published in: Clinical & Experimental Allergy

DOI: 10.1111/cea.70278

Field-Weighted Citation Impact: 0.00

Command Palette

Depot Extracts for Venom Immunotherapy: A Delphi Consensus on Safety and Efficacy

Authors

Abstract

Topics & Keywords

Publication Details